As filed with the Securities and Exchange Commission on March 4, 2025
Registration No. 333-283150
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
POST-EFFECTIVE AMENDMENT NO. 1
TO
FORM S-1
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT
OF 1933
EMERGENT BIOSOLUTIONS INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
| Delaware |
|
2834 |
|
14-1902018 |
| (State or other jurisdiction of
incorporation or organization) |
|
(Primary Standard Industrial
Classification Code Number) |
|
(I.R.S. Employer
Identification No.) |
300 Professional Drive
Gaithersburg, Maryland 20879
(240) 631-3200
(Address, including zip code, and telephone number, including area code, of Registrant’s principal executive offices)
Richard S. Lindahl
Executive Vice President, Chief Financial Officer and Treasurer
Emergent BioSolutions Inc.
300 Professional Drive
Gaithersburg, Maryland 20879
(240) 631-3200
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copies to:
|
|
|
| Matthew C. Franker
Julie M. Plyler
Covington & Burling LLP
One CityCenter 850 Tenth
Street, N.W. Washington, D.C. 20001
(202) 662-6000 |
|
Jessica Perl
Senior Vice President, General Counsel and Corporate Secretary
Emergent BioSolutions Inc.
300 Professional Drive
Gaithersburg, Maryland 20879
(240) 631-3200 |
Approximate date of commencement of proposed sale to the public:
From time to time after the effective date of this registration statement.
If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of
1933, check the following box. ☒
If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the
Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement for the same offering. ☐
If this Form is a
post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting
company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
|
|
|
|
|
|
|
| Large accelerated filer |
|
☐ |
|
Accelerated filer |
|
☒ |
|
|
|
|
| Non-accelerated filer |
|
☐ |
|
Smaller reporting company |
|
☐ |
|
|
|
|
|
|
|
|
Emerging growth company |
|
☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of Securities Act. ☐
This filing constitutes Post-Effective Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-283150), which was initially declared effective on December 4, 2024. This Post-Effective Amendment No. 1 shall become effective immediately upon filing with the Securities and Exchange
Commission in accordance with Rule 462(d) under the Securities Act of 1933, as amended.
